Trials / Completed
CompletedNCT00191399
Bipolar Depression Study: Bipolar Depression Assessment Study on Treatment Response
Bipolar Depression Assessment Study on Tx Response
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 150 (planned)
- Sponsor
- Eli Lilly and Company · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to assess the efficacy of olanzapine and fluoxetine combined on all the visits as compared with the baseline visit in patients with bipolar disorder, measured by the total score of the Montgomery-Asberg Depression Rating Scale (MADRS).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Olanzapine | |
| DRUG | Fluoxetine |
Timeline
- Start date
- 2004-05-01
- Completion
- 2006-03-01
- First posted
- 2005-09-19
- Last updated
- 2007-01-26
Locations
10 sites across 2 countries: United States, Puerto Rico
Source: ClinicalTrials.gov record NCT00191399. Inclusion in this directory is not an endorsement.